Outcome of the consolidation and maintenance randomizations
| . | Consolidation . | Maintenance . | ||
|---|---|---|---|---|
| Short . | Long . | IFN . | None . | |
| No. of patients | 185 | 186 | 182 | 180 |
| Deaths in first complete remission, % dying | 3 | 8 | 5 | 5 |
| Relapse risk, % at 5 years | 81 | 73 | 77 | 81 |
| Disease-free survival, % at 5 years | 16 | 23 | 20 | 15 |
| Overall survival, % at 5 years | 23 | 22 | 21 | 20 |
| . | Consolidation . | Maintenance . | ||
|---|---|---|---|---|
| Short . | Long . | IFN . | None . | |
| No. of patients | 185 | 186 | 182 | 180 |
| Deaths in first complete remission, % dying | 3 | 8 | 5 | 5 |
| Relapse risk, % at 5 years | 81 | 73 | 77 | 81 |
| Disease-free survival, % at 5 years | 16 | 23 | 20 | 15 |
| Overall survival, % at 5 years | 23 | 22 | 21 | 20 |
IFN indicates interferon.